The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
The Association Between Selective Serotonin Reuptake Inhibitors and Glycemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Open accessAbstract
Objective: Individual studies have reported conflicting effects of selective serotonin reuptake inhibitors (SSRIs) on glycemia. We systematically reviewed the effects of SSRIs on glycemia and whether metabolic and psychological factors moderated these effects. Methods: We systematically searched for placebo-controlled randomized controlled trials investigating the effect of SSRIs on glycemia (fasting blood glucose or HbA1c) as a primary or secondary outcome. Random effects meta-analysis was conducted to compute an overall treatment effect. Meta-regression tested whether depression, type 2 diabetes, insulin resistance, treatment duration, and weight loss moderated treatment effects. Results: Sixteen randomized controlled trials ( n = 835) were included and glycemia was usually a secondary outcome. Overall, SSRIs improved glycemia versus placebo (pooled effect size (ES) = − 0.34, 95% confidence interval (CI) = −0.48 to −0.21; p < .001, I 2 = 0%). Individually, fluoxetine (ES = − 0.29, 95% CI = −0.54 to −0.05; p = .018) and escitalopram/citalopram (ES = − 0.33, 95% CI = −0.59 to −0.07; p = .012) outperformed placebo, but paroxetine (ES = − 0.19, 95% CI = −0.58 to 0.19; p = .33) did not. Results were similar in populations selected for depression as those not. Across studies, baseline insulin resistance ( p = .46), treatment duration ( p = .47), diabetes status ( p = .41), and weight loss ( p = .93) did not moderate changes. Heterogeneity for all analyses was nonsignificant. Conclusions: SSRIs seem to have an association with improvement in glycemia, which is not moderated by depression status, diabetes status, or change in weight across studies. Future powered trials with longer treatment duration are needed to confirm these findings. Registration: PROSPERO ID: CRD4201809239.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
The Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32802-7 · Cited by 3,541
How should meta‐regression analyses be undertaken and interpreted?
Thompson, S. G., & Higgins, J. P. T. (2002) · Statistics in Medicine · doi:10.1002/sim.1187 · Cited by 3,026
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981
The heterogeneity statistic I2 can be biased in small meta-analyses
von Hippel, P. T. (2015) · BMC Medical Research Methodology · doi:10.1186/s12874-015-0024-z · Cited by 1,229 · cited 1×
“It should be stressed that the I 2 value is an estimate of heterogeneity that can be imprecise, particularly in smaller meta-analyses (53).”
Result
Research works printed but not linked: 1
- 2016, The selective serotonin reuptake inhibitor fluoxetine promotes insulin secretion and maintains functional beta cell mass, Diabet Med, 33, 20
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Antidepressant use and risk of adverse outcomes: population-based cohort study
Bansal, N., Hudda, M., Payne, R. A., Smith, D. J., Kessler, D., & Wiles, N. (2022) · BJPsych Open · doi:10.1192/bjo.2022.563 · Cited by 66
Antidepressants use and the risk of type 2 diabetes mellitus: A systematic review and meta-analysis
Wang, Y., Liu, D., Li, X., Liu, Y., & Wu, Y. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.03.023 · Cited by 44
Effects of selective serotonin reuptake inhibitors on endocrine system (Review)
Ruiz‐Santiago, C., Rodríguez‐Pinacho, C., Pérez‐Sánchez, G., & Acosta-Cruz, E. (2024) · Biomedical Reports · doi:10.3892/br.2024.1816 · Cited by 41
Srisurapanont, M., Suttajit, S., Kosachunhanun, N., Likhitsathian, S., Suradom, C., & Maneeton, B. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104731 · Cited by 31
Metadata
- Authors
- Tharmaraja, T., Stahl, D., Hopkins, C. W. P., Persaud, S. J., Jones, P. M., Ismail, K., & Moulton, C. D.
- Affiliations
- King's College London (GB)
- Corresponding author
- Moulton, Calum D.
- ORCID
- Venue
- Psychosomatic Medicine
- Published
- 2019-05-13
- Volume
- 81
- Issue
- 7
- Pages
- 570-583
- ISSN
- 0033-3174 (ISSN-L)
- 1534-7796
- OpenAlex
- W2945494482
- Cited by
- 35
- References
- 47
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 3 · 2023: 2 · 2022: 10 · 2021: 3 · 2020: 4 · 2019: 3
- FWCI
- 0.64
- Type
- journal article
- Language
- en
- Open access
- green
- kclpure.kcl.ac.uk
- Licence
- other-oa
- Locations
- Psychosomatic Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Funders
- Eli Lilly and Company
- Sanofi
- Royal College of Physicians of Edinburgh
- National Institute for Health and Care Research
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- selective serotonin reuptake inhibitors, glycemia, fasting blood glucose, HbA1c, depression, type 2 diabetes, insulin resistance, fluoxetine, paroxetine, escitalopram, citalopram, weight loss
- MeSH terms
- Blood Glucose, Depressive Disorder, Glycated Hemoglobin, Humans, Comorbidity, Randomized Controlled Trials as Topic, Selective Serotonin Reuptake Inhibitors, Glucose Metabolism Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Association Between Selective Serotonin Reuptake Inhibitors and Glycemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. https://app.cochat.ai/papers/10.1097/psy.0000000000000707
- The paper
- Tharmaraja, T., Stahl, D., Hopkins, C. W. P., Persaud, S. J., Jones, P. M., Ismail, K., & Moulton, C. D. (2019). The Association Between Selective Serotonin Reuptake Inhibitors and Glycemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Psychosomatic Medicine. https://doi.org/10.1097/psy.0000000000000707
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.